Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 4NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Precancerous Conditions 23Papillomavirus Infections 7Lymphoma 6HIV Infections 6Squamous Intraepithelial Lesions 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic Syndromes 4Multiple Myeloma 4Monoclonal Gammopathy of Undetermined Significance 4Leukemia, Myeloid, Acute 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Biphenotypic, Acute 4Leukemia 4Anus Neoplasms 4Waldenstrom Macroglobulinemia 3Primary Myelofibrosis 3Neoplasms, Plasma Cell 3Neoplasms 3Myeloproliferative Disorders 3Leukemia, Prolymphocytic 3Leukemia, Myelomonocytic, Chronic 3Immunoglobulin Light-chain Amyloidosis 3Uterine Cervical Dysplasia 2Thrombocythemia, Essential 2Squamous Cell Carcinoma of Head and Neck 2Sezary Syndrome 2Prostatic Neoplasms 2Preleukemia 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Polycythemia Vera 2

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Atypical Squamous Cells of the Cervix × Other neoplasm × Clear all
NCT00513526 2023-11-14

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

AIDS Malignancy Consortium

Phase 2 Completed
112 enrolled 16 charts
GynecologicOther neoplasm

Squamous Intraepithelial Lesions, Infections, Precancerous Conditions, Atypical Squamous Cells of the Cervix

Data powered by HemOnc (CC BY 4.0) Colophon âš¡